Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Common Equity (2020 - 2026)

Trulieve Cannabis has reported Common Equity over the past 6 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 8.49% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 8.49%, while the annual FY2025 figure was $1.1 billion, 8.49% down from the prior year.
  • Common Equity for Q4 2025 was $1.1 billion at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
  • Over five years, Common Equity peaked at $2.1 billion in Q4 2021 and troughed at $485.6 million in Q1 2021.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: surged 379.43% in 2021 and later crashed 31.04% in 2023.
  • Year by year, Common Equity stood at $2.1 billion in 2021, then decreased by 10.23% to $1.9 billion in 2022, then decreased by 26.93% to $1.4 billion in 2023, then dropped by 11.33% to $1.2 billion in 2024, then dropped by 8.49% to $1.1 billion in 2025.
  • Business Quant data shows Common Equity for TCNNF at $1.1 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.